It has been demonstrated that the cross-talk between MM cells and BM stromal cells (MSCs) promotes tumor survival, by suppressing CD4+ T cells activity through the PD-L1/PD-1 axis [36]. Here, CD4 is linked to Miyoshi myopathy.